Back
Corcept Therapeutics Stock Price Chart
From 50,000 investors to Nasdaq? Mode's next move...
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Buy
67
CORT
Corcept Therapeutics
Last Price:
$71.71
Seasonality Move:
2.87%
7 Day Trial
ALL ACCESS PASS
$
7
Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
The current trend is moderately bearish and CORT is experiencing slight buying pressure.
Corcept Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.06 | Buy |
| 20-day SMA: | 74.14 | Buy |
| 50-day SMA: | 71.51 | Buy |
| 200-day SMA: | 56.34 | Buy |
| 8-day EMA: | 76.75 | Buy |
| 20-day EMA: | 74.29 | Buy |
| 50-day EMA: | 63.13 | Buy |
| 200-day EMA: | 28.29 | Buy |
Corcept Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.36 | Buy |
| Relative Strength Index (14 RSI): | 59.56 | Buy |
| Chaikin Money Flow: | 437201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.01 - 76.35) | Buy |
| Bollinger Bands (100): | (55.95 - 75.89) | Buy |
Corcept Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics Stock
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 77.56 while CORT 8-day simple moving average is 77.06, which is a Buy signal.
-
The stock price of CORT is 77.56 while Corcept Therapeutics 20-day SMA is 74.14, which makes it a Buy.
-
Corcept Therapeutics 50-day simple moving average is 71.51 while CORT share price is 77.56, making it a Buy technically.
-
CORT stock price is 77.56 and Corcept Therapeutics 200-day simple moving average is 56.34, creating a Buy signal.
CORT Technical Analysis vs Fundamental Analysis
Buy
67
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy or a Sell?
-
Corcept Therapeutics stock is rated a BuyThe current Corcept Therapeutics [CORT] share price is $77.56. The Score for CORT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Corcept Therapeutics Stock Info
Market Cap:
8.2B
Price in USD:
77.56
Share Volume:
1.2M
Corcept Therapeutics 52-Week Range
52-Week High:
117.33
52-Week Low:
28.04
Buy
67
Corcept Therapeutics (CORT)
is a Buy
Corcept Therapeutics Share Price Forecast
-
What is the Corcept Therapeutics stock price today?The Corcept Therapeutics stock price is 77.56 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics is not overvalued.
Is Corcept Therapeutics Stock a Buy?
-
Corcept Therapeutics share price is 77.56 while CORT 8-day exponential moving average is 76.75, which is a Buy signal.
-
The stock price of CORT is 77.56 while Corcept Therapeutics 20-day EMA is 74.29, which makes it a Buy.
-
Corcept Therapeutics 50-day exponential moving average is 63.13 while CORT share price is 77.56, making it a Buy technically.
-
CORT stock price is 77.56 and Corcept Therapeutics 200-day simple moving average is 28.29, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics
Is Corcept Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.
Technical Analysis of Corcept Therapeutics
Should I short Corcept Therapeutics stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 3.36, suggesting Corcept Therapeutics is a Buy
-
Corcept Therapeutics Relative Strength Index (RSI) is 59.56, which suggest Corcept Therapeutics is overbought
-
The Bollinger Bands (25) for Corcept Therapeutics is (71.01 - 76.35), which suggest Corcept Therapeutics is a Buy
-
The Bollinger Bands (100) for Corcept Therapeutics is (55.95 - 75.89), which suggest Corcept Therapeutics is a Buy
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.